Boothbay Fund Management LLC Reduces Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

Boothbay Fund Management LLC cut its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 95.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,215 shares of the health services provider's stock after selling 46,330 shares during the period. Boothbay Fund Management LLC's holdings in Amedisys were worth $201,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after purchasing an additional 124 shares during the period. HBW Advisory Services LLC bought a new position in shares of Amedisys during the 4th quarter worth $38,000. Versant Capital Management Inc grew its holdings in Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after acquiring an additional 183 shares in the last quarter. Vestcor Inc purchased a new position in shares of Amedisys in the 4th quarter valued at $73,000. Finally, Venturi Wealth Management LLC lifted its holdings in shares of Amedisys by 397.4% during the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock valued at $89,000 after purchasing an additional 779 shares during the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AMED has been the topic of several recent analyst reports. Royal Bank of Canada restated an "outperform" rating and set a $100.00 price objective on shares of Amedisys in a report on Wednesday, April 16th. Stephens reaffirmed an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $100.75.

Amedisys Price Performance

AMED traded down $0.12 during trading on Tuesday, reaching $96.13. The company's stock had a trading volume of 364,448 shares, compared to its average volume of 415,333. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a fifty day simple moving average of $92.76 and a two-hundred day simple moving average of $91.72. The company has a market cap of $3.15 billion, a price-to-earnings ratio of 38.15, a PEG ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. The company had revenue of $594.78 million for the quarter, compared to the consensus estimate of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Amedisys's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.03 earnings per share. As a group, analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.